Management of Hepatitis B Surface Antigen and Hepatitis C Antibody-Positive Patients by Departments Not Specializing in Hepatology at a Suburban University Hospital in Japan: A Single-Center Observational Study [Corrigendum]

This article refers to:

Management of Hepatitis B Surface Antigen and Hepatitis C Antibody-Positive Patients by Departments Not Specializing in Hepatology at a Suburban University Hospital in Japan: A Single-Center Observational Study

Tokushima Y, Tago M, Tokushima M, et al. Int J Gen Med. 2020;13:743—750.

The authors have advised there are errors in Table 1 on page 746 in the Hbs-Ag positive patients’ data. The errors were introduced during the creation of the Table.

Table 1 Characteristics of Hepatitis B Surface Antigen-Positive Patients and with Moderate to High Titers of Hepatitis C Virus Antibodies

	HBs-Ag-Positive		Moderate to High HCV-Ab Titers
Age (years)	62.1	± 17.7	69.3	± 15.4
Male sex	36	43.9%	142	50.9%
Internal medicine department	16	19.5%	60	21.5%
PLT (×10^4/μL)	20.0	± 7.7	17.2	± 6.9
AST (U/L)	55.5	± 221.9	36.8	± 40.4
ALT (U/L)	67.6	± 366.5	26.2	± 23.4
γ-GTP (U/L)	34.8	± 33.8	36.9	± 42.2
HBs-Ag (IU/mL)	3967.2	± 12371.6	-	-
HCV-Ab (S/CO)	-	-	12.8	± 3.8
Referred group	29	35.4%	33	11.8%

Notes: Nominal variables are expressed as numbers and percentages, continuous variables are expressed as mean and standard deviation.Abbreviations: PLT, platelet count; AST, aspartate aminotransferase; ALT, alanine aminotransferase; γ-GTP, γ-glutamyl transpeptidase; HBs-Ag, hepatitis B surface antigen; HCV-Ab, hepatitis C virus antibody.

The correct Table 1 is shown below:

The errors were only in the patients’ background and do not affect the main results (consultation rate, comparison of RF and non-RF groups), discussion, or conclusion of the paper.

The authors apologize for these errors.